Results 261 to 270 of about 69,426 (314)

Medications Used Among Nonhospitalized Pregnant Women With COVID‐19: A Prospective Individual Patient Data Meta‐Analysis in Europe and North America

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 1, January 2026.
ABSTRACT Aim To estimate the prevalence of medication use in nonhospitalized pregnant women with COVID‐19. Methods A prospective two‐stage individual patient meta‐analysis across 10 data sources in Europe and North America studied medication use among nonhospitalized pregnant women with COVID‐19 between January 2020 and December 2022.
Odette de Bruin, Emeline Maisonneuve, Eimir Hurley, Hedvig M. E. Nordeng, Anick Bérard, Odile Sheehy, Padma Kaul, Mayura U. Shinde, Austin Cosgrove, Jennifer G. Lyons, Elizabeth Messenger‐Jones, Maria E. Kempner, Sengwee Toh, Wei Hua, José J. Hernández‐Muñoz, Leyla Sahin, Carolyn E. Cesta, David Hägg, Rosa Gini, Olga Paoletti, Beatriz Poblador‐Plou, Sue Jordan, Daniel Thayer, Clara L. Rodríguez‐Bernal, Francisco Sánchez‐Sáez, Régis Lassalle, Marie‐Agnès Bernard, Ema Alsina, Fariba Ahmadizar, Guillaume Favre, Alice Panchaud, Kitty W. M. Bloemenkamp, Kelly Plueschke, Corinne de Vries, Satu J. Siiskonen, Miriam C. J. M. Sturkenboom, on behalf of the CONSIGN Collaboration Group, Benjamin P. Geisler, Mark Walker, Steven Hawken, Sasha Bernatsky, Sherif Eltonsy, Emma Hoffman, Andrew B. Petrone, Jolene Mosley, Jenice Ko, Claudia Bartolini, Giuseppe Roberto, Giorgio Limoncella, Anna Girardi, Giulia Hyeraci, Antonio Gimeno‐Miguel, Jonás Carmona‐Pírez, Antonio Poncel‐Falcó, Aida Moreno‐Juste, Alexandra Prados‐Torres, Ian Farr, Saira Ahmed, Ieuan Scanlon, Gabriel Sanfélix‐Gimeno, Isabel Hurtado, Anibal Garcia‐Sempere, Salvador Peiro, Jérémy Jové, Dunia Sakr, Cécile Droz‐Perroteau, David Baum, Hilde M. Engjom, Mònica Sabaté Gallego, Elena Ballarín Alins, Cristina Aguilera Martin, Melissa Kampman, Celline Brasil   +72 more
wiley   +1 more source

Cohort event monitoring of booster COVID-19 vaccine safety using patient-reported outcomes in pregnant women. [PDF]

Front Drug Saf Regul
Maisonneuve E, Luxi N, Bellitto C, Ciccimarra F, Raethke M, van Hunsel F, Lieber T, Mulder E, Riefolo F, Villalobos F, Thurin NH, Batel-Marques F, Morton K, O'Shaughnessy F, Cleary B, Sonderlichová S, Farcas A, Bucsa C, Favre G, Siiskonen SJ, Baud D, Sturkenboom MCJM, Trifirò G, Panchaud A.   +23 more
europepmc   +1 more source

GP Consultations for Venous Thromboembolism (VTE) After mRNA and Adeno‐Vector‐Based COVID‐19 Vaccination—An Exposure‐Anchored Self‐Controlled Cohort Study Based on Primary Healthcare Data From the Netherlands

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 1, January 2026.
ABSTRACT Introduction Venous thromboembolism (VTE) is labeled as an adverse effect of the adeno‐vector‐based vaccines AstraZeneca and Johnson & Johnson. We aimed to study whether there was an increase in general practitioner (GP) consultations for VTE after COVID‐19 vaccination.
R. Jajou, E. P. van Puijenbroek, K. Hek, J. A. Overbeek, F. P. A. M. van Hunsel, Erik Mulder, A. C. Kant   +6 more
wiley   +1 more source

Commentary: Musculoskeletal adverse events in dogs receiving bedinvetmab (Librela). [PDF]

Front Vet Sci
Lloyd A.
europepmc   +1 more source

Dermatologic Adverse Events Associated With Chimeric Antigen Receptor T-Cell Therapy: A Pharmacovigilance Analysis of the FDA Reporting System

Ryan Storgard, Stephen W. Dusza, Roni Shouval, Michael Scordo, Alina Markova   +4 more
openalex   +1 more source

Expanding Cystic Fibrosis Registries to the Rest of the World

Pediatric Pulmonology, Volume 61, Issue 1, January 2026.
ABSTRACT Challenge Cystic fibrosis (CF) is a global challenge. The epidemiological knowledge is incomplete and focused on patient registries in the United States, Canada, Europe, Australia and New Zealand, Brazil, and South Africa. To complete the global picture of CF, we have to learn from each individual with CF, as well as each cohort and population.
Lutz Naehrlich
wiley   +1 more source

Stigma, Scarcity and the Price of Legitimacy: Chronic Pain Advocacy and the Politics of Pharmaceutical Partnerships in Canada

Sociology of Health &Illness, Volume 48, Issue 1, January 2026.
ABSTRACT This study examines how chronic pain advocates in Canada navigated fraught relationships with pharmaceutical companies amid escalating concerns about the adverse public health impacts of opioids. Drawing on 22 qualitative interviews with professional chronic pain advocates, it examines how advocates navigated their complex relationships with ...
Daniel Eisenkraft Klein, Benjamin Hawkins, Quinn Grundy, Robert Schwartz   +3 more
wiley   +1 more source

Mining and analysis of drug-induced shock adverse reactions: A comprehensive pharmacovigilance study based on the US FAERS database. [PDF]

PLoS One
Lai J, Pan Y, Hu J, Tang Z.
europepmc   +1 more source

Cardiovascular safety of testosterone therapy—Insights from the TRAVERSE trial and beyond: A position statement of the European Expert Panel for Testosterone Research

Andrology, Volume 14, Issue 1, Page 294-302, January 2026.
Abstract Introduction Testosterone therapy has become a cornerstone treatment for men with hypogonadism, offering significant benefits such as improved sexual function, mood, muscle mass, and bone density. However, concerns about its cardiovascular safety have historically tempered its use.
Michael Zitzmann, Giulia Rastrelli, Robert D Murray, David Edwards, Yacov Reisman, Preethi Mohan Rao, Alexander Sahi, Thomas Hugh Jones, Alberto Ferlin, Eleni Armeni, Emiliano Corpas, Jann‐Frederik Cremers, Janine David, Stefan Arver, Leen Antonio, Giovanni Corona   +15 more
wiley   +1 more source

Body‐identical estrogens in combined hormonal contraceptives: A safer path forward

International Journal of Gynecology &Obstetrics, Volume 172, Issue 1, Page 654-656, January 2026.
Nathalie Chabbert‐Buffet, Ivonne J. Diaz Yamal, Jonathan Douxfils, Jean‐Michel Foidart, Franca Fruzzetti, Kristina Gemzell‐Danielsson, Rossella E. Nappi, Yutaka Osuga, Philippe Descamps   +8 more
wiley   +1 more source